Advertisement

Topics

Rosetta Genomics Ltd.: Major Clinical Reference Laboratory Selects RosettaGX Reveal Thyroid miRNA Classifier as Molecular Test of Choice

08:09 EDT 21 Aug 2017 | FinanzNachrichten

Laboratory's Entire Sales Team to Promote Reveal to All its Customers Throughout the Southwestern United States PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / August 21, 2017 / Rosetta Genomi...

Original Article: Rosetta Genomics Ltd.: Major Clinical Reference Laboratory Selects RosettaGX Reveal Thyroid miRNA Classifier as Molecular Test of Choice

NEXT ARTICLE

More From BioPortfolio on "Rosetta Genomics Ltd.: Major Clinical Reference Laboratory Selects RosettaGX Reveal Thyroid miRNA Classifier as Molecular Test of Choice"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...